Validation of CP‐GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: A U.S. cohort study by Yousaf, Ahmed, Tjien‐Fooh, Félicia J., Rentroia‐Pacheco, Barbara, Quattrocchi, Enrica, Kobic, Ajdin, Tempel, Dennie, Kolodney, Michael, Meves, Alexander

Get full text

Clinicopathologic models predicting non‐sentinel lymph node metastasis in cutaneous melanoma patients: Are they useful for patients with a single positive sentinel node? by Rentroia‐Pacheco, Barbara, Tjien‐Fooh, Félicia J., Quattrocchi, Enrica, Kobic, Ajdin, Wever, Renske, Bellomo, Domenico, Meves, Alexander, Hieken, Tina J.

Get full text

Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model by Eggermont, Alexander M.M., Bellomo, Domenico, Arias-Mejias, Suzette M., Quattrocchi, Enrica, Sominidi-Damodaran, Sindhuja, Bridges, Alina G., Lehman, Julia S., Hieken, Tina J., Jakub, James W., Murphree, Dennis H., Pittelkow, Mark R., Sluzevich, Jason C., Cappel, Mark A., Bagaria, Sanjay P., Perniciaro, Charles, Tjien-Fooh, Félicia J., Rentroia-Pacheco, Barbara, Wever, Renske, van Vliet, Martin H., Dwarkasing, Jvalini, Meves, Alexander

Get full text

Enhanced Risk Stratification for Sentinel Lymph Node Biopsy in Head and Neck Melanoma Using the Merlin Assay (CP-GEP) by Pazhava, Ani, Yu, Wesley Y, Jing, Frank Z, Hill, Sheena, Rohr, Bethany R, Honda, Kord S, Tjien-Fooh, Félicia, Wever, Renske, Dwarkasing, Jvalini, Hieken, Tina J, Meves, Alexander

Get full text